BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19546429)

  • 1. US surveillance of regional lymph node recurrence after breast cancer surgery.
    Moon HJ; Kim MJ; Kim EK; Park BW; Youk JH; Kwak JY; Sohn J; Kim SI
    Radiology; 2009 Sep; 252(3):673-81. PubMed ID: 19546429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
    Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
    Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy.
    van Rijk MC; Deurloo EE; Nieweg OE; Gilhuijs KG; Peterse JL; Rutgers EJ; Kröger R; Kroon BB
    Ann Surg Oncol; 2006 Jan; 13(1):31-5. PubMed ID: 16372147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
    Reddy SG; Kiel KD
    Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment axillary ultrasonography and core biopsy in patients with suspected breast cancer: diagnostic accuracy and impact on management.
    Garcia-Ortega MJ; Benito MA; Vahamonde EF; Torres PR; Velasco AB; Paredes MM
    Eur J Radiol; 2011 Jul; 79(1):64-72. PubMed ID: 20047809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer--correlation with primary tumor size.
    Koelliker SL; Chung MA; Mainiero MB; Steinhoff MM; Cady B
    Radiology; 2008 Jan; 246(1):81-9. PubMed ID: 17991784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
    Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
    Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding MRI to ultrasound and ultrasound-guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients.
    Hyun SJ; Kim EK; Yoon JH; Moon HJ; Kim MJ
    Clin Radiol; 2015 Jul; 70(7):716-22. PubMed ID: 25917544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery.
    Park VY; Kim EK; Moon HJ; Yoon JH; Kim MJ
    Am J Surg; 2018 Nov; 216(5):969-973. PubMed ID: 29709272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of ultrasound for postoperative surveillance of asian patients with history of breast cancer surgery: a single-center study.
    Suh YJ; Kim MJ; Kim EK; Moon HJ; Kim SI; Park BW
    Ann Surg Oncol; 2013 Oct; 20(11):3461-8. PubMed ID: 23695431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound Imaging for Detecting Metastasis to Level II and III Axillary Lymph Nodes after Axillary Lymph Node Dissection for Invasive Breast Cancer.
    Lin X; An X; Xiang H; Pei X; Li A; Tang G
    J Ultrasound Med; 2019 Nov; 38(11):2925-2934. PubMed ID: 30912182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
    Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
    Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].
    Zhang W; Qi XM; Chen AX; Zhang P; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):374-379. PubMed ID: 28535656
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE; Hwang WT; Seyednejad F; Solin LJ
    Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
    Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
    Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Year follow-up of sentinel node negative breast cancer patients.
    de Kanter AY; Menke-Pluymers MM; Wouters MW; Burgmans I; van Geel AN; Eggermont AM
    Eur J Surg Oncol; 2006 Apr; 32(3):282-6. PubMed ID: 16439094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients.
    Zgajnar J; Hocevar M; Podkrajsek M; Hertl K; Frkovic-Grazio S; Vidmar G; Besic N
    Breast Cancer Res Treat; 2006 Jun; 97(3):293-9. PubMed ID: 16333526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
    Ohsumi S; Inoue T; Kiyoto S; Hara F; Takahashi M; Takabatake D; Takashima S; Aogi K; Takashima S
    Breast Cancer Res Treat; 2011 Nov; 130(1):267-72. PubMed ID: 21590272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.